Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Imprimis Phar (IMMY)

Imprimis Phar (IMMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Imprimis Phar 12264 El Camino Real Suite 350 San Diego CA 92130 USA

www.imprimisrx.com P: 858-704-4040

Description:

Imprimis Pharmaceuticals, Inc. is a pharmaceutical company focused on its proprietary ophthalmology and urology drug formulations. Imprimis recently launched its urology business, which includes a patented formulation to address patients suffering from interstitial cystitis.

Key Statistics

Overview:

Market Capitalization, $K 132,463
Shares Outstanding, K 23,280
Annual Sales, $ 26,770 K
Annual Net Income, $ -11,990 K
Last Quarter Sales, $ 10,740 K
Last Quarter Net Income, $ -2,510 K
60-Month Beta -1.00
% of Insider Shareholders 13.78%
% of Institutional Shareholders 16.11%

Growth:

1-Year Return 234.71%
3-Year Return -9.68%
5-Year Return 27.58%
5-Year Revenue Growth 26,670.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/13/18
Earnings Per Share ttm -0.30
EPS Growth vs. Prev Qtr -200.00%
EPS Growth vs. Prev Year 57.14%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 02/08/13

IMMY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 8.25
Price/Earnings to Growth N/A
Return-on-Equity % -231.16%
Return-on-Assets % -25.18%
Profit Margin % -44.79%
Debt/Equity 5.64
Price/Sales 4.51
Price/Cash Flow N/A
Price/Book 26.92
Book Value/Share -0.21
Interest Coverage -3.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar